Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 233.653 |
|
|||||
| News | - | ||||||
| Tageshoch | 7,41 | Niedrig Hoch |
|||||
| Tagestief | 6,92 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 7,04 | 17:33:46 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 6,99 | 6,92 | 7,41 | 7,04 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 721 | 233.653 | US$ 7,06 | US$ 1.648.670 | - | 2,86 - 11,41 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 17:34:43 | 1 | US$ 7,04 | USD |
Finanzwerte VRCA
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 299,06M | 42,42M | - | 5,12M | -67M | -1,58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Verrica Parmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 10.6.2024 | 22:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.6.2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 07.6.2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 15.5.2024 | 13:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.5.2024 | 22:31 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 13.5.2024 | 14:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13.5.2024 | 13:46 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.2.2024 | 14:05 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 29.2.2024 | 13:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08.1.2024 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16.11.2023 | 22:49 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 16.11.2023 | 22:35 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Verrica Parmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
VRCA Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 7,90 | 8,1399 | 6,88 | 7,22 | 286.993 | -0,86 | -10,89% |
| 1 Monat | 8,29 | 9,36 | 6,88 | 8,09 | 184.671 | -1,25 | -15,08% |
| 3 Monate | 5,88 | 11,41 | 5,79 | 7,85 | 215.996 | 1,16 | 19,73% |
| 6 Monate | 6,78 | 11,41 | 4,60 | 6,94 | 192.453 | 0,26 | 3,83% |
| 1 Jahr | 5,96 | 11,41 | 2,86 | 5,93 | 463.176 | 1,08 | 18,12% |
| 3 Jahre | 11,60 | 14,789 | 1,77 | 5,65 | 271.011 | -4,56 | -39,31% |
| 5 Jahre | 9,53 | 18,67 | 1,77 | 6,73 | 199.574 | -2,49 | -26,13% |
